| Date | Title | Description |
| 09.05.2024 | Dr. Tiffany Chen Joins Techcyte as Medical Director | OREM, UT, USA, May 9, 2024 /EINPresswire.com/ -- Techcyte is excited to announce Dr. Tiffany Y. Chen, MD recently joined the Techcyte team as a medical director. Dr. Chen’s expertise in clinical, anatomic, and computational pathology will a... |
| 27.02.2024 | Techcyte Strengthens Global Presence with New Expert Solution Providers and its First Annual Channel Conference | OREM, UT, USA, February 27, 2024 /EINPresswire.com/ -- Techcyte continues to expand its routes to market through the Techcyte Expert Solution Provider (ESP) program. Seven new companies recently joined the program and will participate in th... |
| 21.02.2024 | Techcyte's Chief Technology Officer, Shane Swenson, Recognized on AI Utah 100 Honoree List | OREM, UTAH, USA, February 20, 2024 /EINPresswire.com/ -- Techcyte, a leading innovator in digital pathology, is proud to announce that its Chief Technology Officer, Shane Swenson, has been included in the AI Utah 100 Honoree List. This reco... |
| 02.02.2024 | Zoetis and Techcyte Introduce a New AI Urine Sediment Analysis to the Vetscan Imagyst® Platform | OREM, UT, USA, February 2, 2024 /EINPresswire.com/ -- Zoetis, in collaboration with Techcyte, is transforming veterinary diagnostics with the introduction of the Vetscan Imagyst® AI Urine Sediment Analysis. This innovative product, powered ... |
| 30.01.2024 | BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing | AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions
BD, a leading global medical technology company, and Techcyte, a world leader in artificial in... |
| 23.01.2024 | Sporecyte Introduces a Professional Air Sampling Pump and Mold Inspector App | OREM, UT, USA, January 23, 2024 /EINPresswire.com/ -- Sporecyte, the industry leader in AI-powered digital mold and particulate analysis, is proud to announce the launch of its groundbreaking Professional Air Sampling Pump and Mold Inspecto... |
| 30.10.2023 | Pramana and Techcyte Form Collaboration to Offer AI-Enabled Scanning for Cytology and Microbiology | Companies to highlight innovative scanning solutions at Pathology Visions Meeting, Oct. 29-31
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and Techcyte, a leading developer of AI-based image analysis so... |
| 26.10.2023 | Pramana and Techcyte Form Strategic Collaboration to Offer AI-enabled Scanning for Cytology and Microbiology | Companies to highlight innovative scanning solutions at Pathology Visions Meeting, Oct. 29-31 CAMBRIDGE, MASS., USA, October 26, 2023 /EINPresswire.com/ -- Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, a... |
| 09.06.2023 | Techcyte Announces Successful Completion of Clinical Validation Study for AI-Assisted Diagnosis of Bacterial Vaginosis | Technologist using Techcyte's Bacteriology BV Gram Analysis software OREM, UT, USA, June 9, 2023/EINPresswire.com/ -- Techcyte, the Clinical Pathology AI Platform, is pleased to announce the successful completion of a clinical validation st... |
| 04.05.2023 | Zoetis Launches AI Dermatology for VETSCAN IMAGYST with Techcyte | OREM, UT, USA, May 4, 2023/EINPresswire.com/ -- In partnership with Zoetis, Techcyte has developed and launched AI-based dermatology algorithms and workflows for VETSCAN IMAGYST, the all-in-one deep learning SaaS platform. AI Dermatology jo... |
| 14.04.2023 | Zoetis Launches 2nd Generation Vetscan Imagyst Ova & Parasite Test | OREM, UTAH, USA, April 14, 2023/EINPresswire.com/ -- As the technology partner behind Zoetis' Vetscan Imagyst™, Techcyte is proud to announce the second generation of its Ova and Parasite test. Since 2019, Techcyte has partnered with Zoetis... |
| 06.04.2023 | Zoetis and Techcyte to Add Equine Fecal Analysis and Equine Digital Cytology to Vetscan Imagyst | OREM, UTAH, USA, April 6, 2023/EINPresswire.com/ -- Zoetis recently added the AI Equine FEC (Fecal Egg Count) test to its Vetscan Imagyst™ platform, featuring AI algorithms and workflows developed by Techcyte. The addition of AI Equine FEC ... |
| 16.03.2023 | Techcyte Presents AI Super-Resolution Image Reconstruction at the USCAP 2023 Trade Show | Artificial Intelligence Super-Resolution Image Reconstruction Is a Promising Solution to Reduce Cost of Digital Pathology Image Storage OREM, UTAH, USA, March 16, 2023 /EINPresswire.com/ -- Techcyte has developed AI super-resolution image r... |
| 14.03.2023 | Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests | Techcyte announced a strategic collaboration with Mayo Clinic to create new AI algorithms and workflows on the Techcyte Clinical Pathology AI Platform.
AiThority Interview : AiThority Interview with Alan Holland, CEO and Founder of Keelvar
... |
| 13.03.2023 | Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests | OREM, Utah–(BUSINESS WIRE)–March 13, 2023–
Techcyte announced today a strategic collaboration with Mayo Clinic to create new AI algorithms and workflows on the Techcyte Clinical Pathology AI Platform.
This press release features multimedia.... |
| 10.02.2023 | Techcyte Adds Grundium Scanner Support and Near Real-time Reporting to Sporecyte | OREM, UTAH, UNITED STATES, February 10, 2023 /EINPresswire.com/ -- Sporecyte, the first AI-powered mold reporting service, added support for the Grundium Ocus 40* scanner enabling a new onsite and near real-time mold analysis service.
This ... |
| 02.02.2023 | Techcyte and CytoBay Complete Initial Validation Studies for AI-Powered Bladder Cancer Screening Solution | OREM, UTAH, USA, February 2, 2023 /EINPresswire.com/ -- Techcyte is proud to announce the completion of initial validation studies for its artificial intelligence-powered Bladder Cancer screening solution. These studies suggest that its dee... |
| 02.02.2023 | New Study by The University of Utah and Techcyte Demonstrates the Value of AI in Organ Transplantation | How Whole Slide Imaging and AI Can Improve Organ Transplants OREM, UTAH, USA, February 2, 2023 /EINPresswire.com/ -- A new study published in the Official Journal of The Transplant Society and International Liver Transplantation Society tit... |
| 24.01.2023 | Techcyte Improves Digital Diagnostic Workflows for Clinical Pathology | Techcyte, the developers of the Clinical Pathology AI Platform, improve the flexibility and efficiency of the platform's digital diagnostic workflows. OREM, UTAH, UNITED STATES, January 24, 2023 /EINPresswire.com/ -- Techcyte, the developer... |
| 19.09.2022 | Techcyte partner NanoSpot.ai announces partnership with Opto to commercialize SARS-CoV-2 Antibody Test in Europe | OREM, UT, UNITED STATES, September 19, 2022 /EINPresswire.com/ -- Techcyte, the clinical pathology AI platform, is proud to congratulate its partner, NanoSpot.ai, on entering into a commercial and distribution agreement with Opto, an Athroa... |
| 05.07.2022 | Techcyte announces the release of their second generation AI for Human Parasites | OREM, UTAH, UNITED STATES , July 5, 2022 /EINPresswire.com/ -- Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, is proud to announce the release of their second-generation solution for Human F... |
| 30.06.2022 | Study confirms the sensitivity of Techcyte’s AI solution for intestinal protozoa detection | OREM, UTAH, UNITED STATES, June 30, 2022 /EINPresswire.com/ -- A study authored by researchers at Quest Diagnostics and presented at ASM Microbe on June 9-12th 2022 in Washington, D.C. provides evidence that the Techcyte technology aids in ... |
| 26.05.2022 | Techcyte and Cytobay Partner to Create Non-Invasive Digital Diagnostic Test for Bladder Cancer | OREM, UT, UNITED STATES, May 26, 2022 /EINPresswire.com/ -- Bladder cancer is one of the most common cancers and has a high recurrence rate. After successful treatment, it is recommended that survivors be tested every three to six months fo... |
| 20.04.2022 | Zoetis adds Techcyte-powered AI Blood Smear Testing to Vetscan Imagyst | OREM, UTAH, UNITED STATES, April 20, 2022 /EINPresswire.com/ -- As the technology engine behind the multi-use AI-driven platform, Vetscan Imagyst, Techcyte is proud to announce the addition of artificial intelligence (AI) blood smear diagno... |
| 21.08.2021 | Techcyte Closes $21M in Funding | Techcyte, a Orem UT-based based digital clinical pathology platform, raised $21M in funding.
The round was led by Zoetis with participation from ARUP Laboratories and investors from previous rounds.
The company intends to use the funds to g... |
| 19.08.2021 | Techcyte Closes $21 Million Funding Round | Techcyte Inc. closed a $21 million funding round to accelerate commercialization of its digital clinical pathology platform. The investors in this round include Zoetis, ARUP Laboratories and investors from previous rounds.
Ben Cahoon, the C... |
| 19.08.2021 | Clinical pathology startup Techcyte lands $21M for company growth and more digital health fundings | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 29.04.2021 | University of Utah : ARUP, and Techcyte Develop NanoSpot.AI, a New Ultra-Fast Test for COVID-19 Antibodies | The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced today that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test. NanoSpot.AI is estimated ... |
| 09.06.2020 | A Whole New Microscopic World: ARUP/Techcyte Publish First Peer-Reviewed Study on AI-based Protozoa Detection | SALT LAKE CITY–(BUSINESS WIRE)–June 9, 2020–
ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI)-based ... |
| 22.01.2019 | Techcyte Secures Worldwide Exclusive Distribution Rights for Vetcyte ParaPro | LINDON, Utah–(BUSINESS WIRE)–January 22, 2019–
Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, secured worldwide exclusive distribution rights for the Vetcyte ParaPro fecal preparation device... |
| 21.01.2019 | Techcyte Launches Vetcyte, an AI-Powered Digital Diagnostics Platform | LINDON, Utah–(BUSINESS WIRE)–January 21, 2019–
Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, has launched Vetcyte, an AI-powered digital diagnostics platform at VMX 2019. Initially, the Vet... |
| 08.01.2019 | Techcyte and ARUP Laboratories partner to deliver AI-based Digital Diagnostics | LINDON, Utah–(BUSINESS WIRE)–January 8, 2019–
Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, and ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laborat... |
| 22.01.2018 | Term Sheet — Monday, January 22 | LET’S TALK LEVERAGE
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
The big takeaway: The tax overhaul has the power to disrupt how potential buyout targets are valued, how quickly PE leaders... |
| 19.01.2018 | Term Sheet — Friday, January 19 | CRYPTO HYBRIDS
Happy Friday, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
HOT TAKES: Yesterday, I wrote about storage startup Omni and its decision to take the majority of its $25 million fundraise in R... |
| 18.01.2018 | Techcyte Closes $4.3 Million Funding Round | OREM, Utah–(BUSINESS WIRE)–January 18, 2018– Techcyte, Inc. closed a $4.3 million funding round to commercialize its digital pathology platform. The investors in this round include investors from previous rounds, employees and strategic par... |
| 18.01.2018 | Techcyte Closes $4.3M Funding Round | Techcyte, Inc., an Orem, UT-based deep learning image analysis platform provider, closed a $4.3m funding round.
Backers included investors from previous rounds, employees and strategic partners.
The funds will be used to commercialize its d... |
| 18.01.2018 | Techcyte Announces $4.3M Financing |
OREM, UT, Techcyte, closed a $4.3 million funding round to commercialize its digital pathology platform.
>> Click here for more funding data on Techcyte
>> To export Techcyte funding data to PDF and Excel, click here
The ... |
